[1] YOUNG
C C,BONOW R H,BARROS G,et al. Magnetic resonance vessel wall imaging in
cerebrovascular diseases[J/OL]. Neurosurg Focus,2019,47(6):E4[2023-11-10].
https://doi.org/10.3171/2019.9.FOCUS19599.
[2] LENG X Y,WONG K S,LIEBESKIND D S. Evaluating
intracranial atherosclerosis rather than intracranial stenosis[J]. Stroke,2014,45(2):645-651.
[3] ZHANG D F,CHEN Y C,CHEN H Y,et al. A high-resolution MRI study
of relationship between remodeling patterns and ischemic stroke in patients
with atherosclerotic middle cerebral artery stenosis[J/OL]. Front Aging
Neurosci,2017,9:140[2023-11-10]. https://doi.org/10.3389/fnagi.2017.00140.
[4] MANDELL D M,MOSSA-BASHA M,QIAO Y,et al. Intracranial vessel wall MRI:principles and expert consensus recommendations of the American
Society of Neuroradiology[J]. AJNR Am J Neuroradiol,2017,38(2):218-229.
[5] CIRILLO L,RUSTICI A,TONI F,et al. Vessel wall MRI:clinical implementation in cerebrovascular disorders-technical
aspects[J]. Radiol Med,2022,127(6):645-651.
[6] WON S Y,CHA J,CHOI H S,et al. High-resolution intracranial
vessel wall MRI findings among different middle cerebral artery territory
infarction types[J]. Korean J Radiol,2022,23(3):333-342.
[7] 中国卒中学会神经介入分会.
症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2022[J]. 中国卒中杂志,2022,17(8):863-888.
Chinese Interventional
Neuroradiology Society of Chinese Stroke Association. Chinese expert consensus
on endovascular treatment for symptomatic intracranial atherosclerotic stenosis
2022[J]. Chin J Stroke,2022,17(8):863-888.
[8] KIECHL S,WILLEIT J. The natural course
of atherosclerosis. Part Ⅱ:vascular remodeling. Bruneck
Study Group[J]. Arterioscler Thromb Vasc Biol,1999,19(6):1491-1498.
[9] VRANIC J E,HARTMAN J B,MOSSA-BASHA M. High-resolution magnetic resonance vessel wall
imaging for the evaluation of intracranial vascular pathology[J]. Neuroimaging
Clin N Am,2021,31(2):223-233.
[10] LI M L,LIN Q Q,LIU Y T,et
al. The clinical value of head-neck joint high-resolution vessel wall imaging
in ischemic stroke[J/OL]. J Stroke Cerebrovasc Dis,2020,29(9):105062[2023-11-10].
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105062.
[11] BAYLAM
GELERI D,WATASE H,CHU
B C,et al. Detection of advanced lesions of
atherosclerosis in carotid arteries using 3-dimensional motion-sensitized
driven-equilibrium prepared rapid gradient echo(3D-MERGE)magnetic resonance imaging as a screening tool[J]. Stroke,2022,53(1):194-200.
[12] KRAWISZ A K,CARROLL B J,SECEMSKY E A. Risk stratification and management of extracranial
carotid artery disease[J]. Cardiol Clin,2021,39(4):539-549.
[13] OOI Y C,GONZALEZ N R. Management of
extracranial carotid artery disease[J]. Cardiol Clin,2015,33(1):1-35.
[14] WEI H Y,ZHANG M Q,LI Y D,et al. Evaluation of 3D
multi-contrast carotid vessel wall MRI:a comparative
study[J]. Quant Imaging Med Surg,2020,10(1):269-282.
[15] NTAIOS G,WINTERMARK M,MICHEL P. Supracardiac atherosclerosis in embolic stroke of
undetermined source:the underestimated source[J]. Eur
Heart J,2021,42(18):1789-1796.
[16] LARSON A S,BRINJIKJI W,LEKAH A,et al. Nonstenotic carotid plaques
and embolic stroke of undetermined source:a
multimodality review[J]. AJNR Am J Neuroradiol,2023,44(2):118-124.
[17] HE W W,LU S S,GE S,et al. Impact on etiology diagnosis by
high-resolution vessel wall imaging in young adults with ischemic stroke or
transient ischemic attack[J]. Neuroradiology,2023,65(6):1015-1023.
[18] WU F,ZHANG M,QI Z G,et
al. Imaging features of vertebrobasilar dolichoectasia combined with posterior
circulation ischemic stroke:a vessel wall magnetic
resonance imaging study[J/OL]. Eur J Radiol,2023,166:110971[2023-11-10].
https://doi.org/10.1016/j.ejrad.2023.110971.
[19] WU G,ZHU C C,WANG H Y,et
al. Co-existing intracranial and extracranial carotid atherosclerosis predicts
large-artery atherosclerosis stroke recurrence:a
single-center prospective study utilizing combined head-and-neck vessel wall
imaging[J]. Eur Radiol,2023,33(10):6970-6980.
[20] MARK I T,NASR D M,HUSTON J,et
al. Embolic stroke of undetermined source and carotid
intraplaque hemorrhage on MRI:a systemic review and
meta-analysis[J]. Clin Neuroradiol,2021,31(2):307-313.
[21] GARDENER H,SACCO R L,RUNDEK T,et al. Race and ethnic disparities
in stroke incidence in the northern Manhattan study[J]. Stroke,2020,51(4):1064-1069.
[22] 门雪娇,陈玮琪,许玉园,等.
穿支动脉粥样硬化病中国专家共识[J]. 中国卒中杂志,2021,16(5):508-514.
MEN X J,CHEN W Q,XU Y Y,et al. Chinese experts consensus on
branch atheromatous disease[J]. Chin J Stroke,2021,16(5):508-514.
[23] 王伊龙. 《穿支动脉粥样硬化病中国专家共识》解读[J].
中国卒中杂志,2021,16(7):728-729.
WANG Y L.
Interpretation of the Chinese
experts consensus on branch atheromatous disease[J]. Chin J Stroke,2021,16(7):728-729.
[24] ARENILLAS J F,DIELEMAN N,BOS D. Intracranial arterial wall imaging:techniques,clinical applicability,and future
perspectives[J]. Int J Stroke,2019,14(6):564-573.
[25] LIN G H,SONG J X,HUANG T D,et
al. Relationship between the stroke mechanism of symptomatic middle cerebral
artery atherosclerotic diseases and culprit plaques based on high-resolution
vessel wall imaging[J/OL]. Front Neurol,2022,13:968417[2023-11-10].
https://doi.org/10.3389/fneur.2022.968417.
[26] CHUNG J W,KIM B J,CHOI B S,et
al. High-resolution magnetic resonance imaging reveals hidden etiologies of
symptomatic vertebral arterial lesions[J]. J Stroke Cerebrovasc Dis,2014,23(2):293-302.
[27] SANNANANJA B,ZHU C C,MOSSA-BASHA M. Vessel wall imaging in cryptogenic stroke[J]. Radiol
Clin North Am,2023,61(3):491-500.
[28] FAKIH R,ROA J A,BATHLA G,et al. Detection and quantification
of symptomatic atherosclerotic plaques with high-resolution imaging in
cryptogenic stroke[J]. Stroke,2020,51(12):3623-3631.
[29] LUO N,SHANG Z Y,TAO L,et al. Atherosclerosis as a potential
cause of deep embolic stroke of undetermined source:a 3
T high-resolution magnetic resonance imaging study[J/OL]. J Am Heart Assoc,2022,11(21):e026737[2023-11-10]. https://doi.org/10.1161/JAHA.122.026737.
[30] KOPCZAK A,SCHINDLER A,BAYER-KARPINSKA A,et al. Complicated carotid
artery plaques as a cause of cryptogenic stroke[J]. J Am Coll Cardiol,2020,76(19):2212-2222.
[31] TAO L,LI X Q,HOU X W,et
al. Intracranial atherosclerotic plaque as a potential cause of embolic stroke
of undetermined source[J]. J Am Coll Cardiol,2021,77(6):680-691.
[32] KAMTCHUM-TATUENE
J,WILMAN A,SAQQUR
M,et al. Carotid plaque with high-risk features in
embolic stroke of undetermined source:systematic review
and meta-analysis[J]. Stroke,2020,51(1):311-314.
[33] JARVIS K,SOULAT G,SCOTT M,et
al. Investigation of aortic wall thickness,stiffness
and flow reversal in patients with cryptogenic stroke:a
4D flow MRI study[J]. J Magn Reson Imaging,2021,53(3):942-952.
[34] NTAIOS G,PEARCE L A,MESEGUER E,et al. Aortic arch
atherosclerosis in patients with embolic stroke of undetermined source:an exploratory analysis of the NAVIGATE ESUS trial[J]. Stroke,2019,50(11):3184-3190.
[35] SUN J,FENG X R,YANG X,et
al. Correlation between characteristics of intracranial atherosclerotic plaques
and ischemic stroke in high-resolution vascular wall MRI[J]. Acta Radiol,2023,64(2):732-740.
[36] OAK S,CUCCHIARA B L,THAU L,et al. Age alters prevalence of left atrial enlargement and
nonstenotic carotid plaque in embolic stroke of undetermined source[J]. Stroke,2022,53(7):2260-2267.
[37] DESTREBECQ
V,SADEGHI N,LUBICZ
B,et al. Intracranial vessel wall MRI in
cryptogenic stroke and intracranial vasculitis[J/OL]. J Stroke Cerebrovasc Dis,2020,29(5):104684[2023-11-10].
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104684.
[38] MAZZACANE F,ZITO A,MAGNO S,et
al. Vessel wall magnetic resonance imaging in COVID-19-associated cryptogenic
ischemic stroke[J]. Eur J Neurol,2022,29(2):615-619.
[39] WRIGHT C B,DONG C H,PEREZ E J,et
al. Subclinical cerebrovascular disease increases the risk of incident stroke
and mortality:the northern Manhattan study[J/OL]. J Am
Heart Assoc,2017,6(9):e004069[2023-11-10].
https://doi.org/10.1161/JAHA.116.004069.
[40] SAKAMOTO Y,SATO S,KURONUMA Y,et al. Factors associated with
proximal carotid axis occlusion in patients with acute stroke and atrial
fibrillation[J]. J Stroke Cerebrovasc Dis,2014,23(5):799-804.
[41] DE FREITAS G R,CARRUZZO A,TSISKARIDZE A,et al. Massive haemorrhagic
transformation in cardioembolic stroke:the role of
arterial wall trauma and dissection[J]. J Neurol Neurosurg Psychiatry,2001,70(5):672-674.
[42] ASRANNA A P,KESAV P,NAGESH C,et
al. Cerebral aneurysms and metastases occurring as a delayed complication of
resected atrial myxoma:imaging findings including high
resolution vessel wall MRI[J]. Neuroradiology,2017,59(5):427-429.
[43] PANTONI L.
Cerebral small vessel disease:from
pathogenesis and clinical characteristics to therapeutic challenges[J]. Lancet
Neurol,2010,9(7):689-701.
[44] 徐群.
脑小血管病影像研究热点概览[J].
中国卒中杂志,2020,15(12):1264-1266.
XU Q. Overview of
imaging research of cerebral small vessel disease[J]. Chin J Stroke,2020,15(12):1264-1266.
[45] JIANG S,CAO T,YAN Y Y,et al.
Lenticulostriate artery combined with neuroimaging markers of cerebral small
vessel disease differentiate the pathogenesis of recent subcortical
infarction[J]. J Cereb Blood Flow Metab,2021,41(8):2105-2115.
[46] ZWARTBOL M
H,VAN DER KOLK A G,KUIJF H J,et al. Intracranial vessel wall
lesions on 7 T MRI and MRI features of cerebral small vessel disease:the SMART-MR study[J]. J Cereb Blood Flow Metab,2021,41(6):1219-1228.
[47] WU Y,WU F,LIU
Y H,et al. High-resolution magnetic resonance imaging
of cervicocranial artery dissection:imaging features
associated with stroke[J]. Stroke,2019,50(11):3101-3107.
[48] RODALLEC M H,MARTEAU V,GERBER S,et al. Craniocervical arterial dissection:spectrum of imaging findings and differential diagnosis[J].
Radiographics,2008,28(6):1711-1728.
[49] LIU Y H,LI S J,WU Y,et al.
The added value of vessel wall MRI in the detection of intraluminal thrombus in
patients suspected of craniocervical artery dissection[J]. Aging Dis,2021,12(8):2140-2150.
[50] KIM J S. Moyamoya disease:epidemiology,clinical features,and diagnosis[J]. J Stroke,2016,18(1):2-11.
[51] IHARA M,YAMAMOTO Y,HATTORI Y,et al. Moyamoya disease:diagnosis and interventions[J]. Lancet Neurol,2022,21(8):747-758.
[52] ZHANG H,ZHENG L J,FENG L. Epidemiology,diagnosis and treatment
of moyamoya disease[J]. Exp Ther Med,2019,17(3):1977-1984.
[53] TAGAWA H,FUSHIMI Y,FUNAKI T,et al. Vessel wall MRI in moyamoya
disease:arterial wall enhancement varies depending on
age,arteries,and disease
progression[J]. Eur Radiol,2024,34(4):2183-2194.
[54] YU L B,SHEN M,ZHANG Q,et al. A vessel wall MRI
investigation in patients with moyamoya or quasi-moyamoya disease:diagnosis,features,and
outcomes[J/OL]. J Craniofac Surg,2024,35(1):e24-e28[2023-11-10].
https://doi.org/10.1097/SCS.0000000000009681.
[55] ARNETT N,PAVLOU A,BURKE M P,et al. Vessel wall MR imaging of
central nervous system vasculitis:a systematic
review[J]. Neuroradiology,2022,64(1):43-58.
[56] KANG H B,BAI X Y,ZHANG Y S,et
al. Predictors of improvement for patients with CNS vasculitis stenoses:a high-resolution vessel wall MRI follow-up study[J/OL]. Eur J
Radiol,2023,158:110619[2023-11-10]. https://doi.org/10.1016/j.ejrad.2022.110619.
[57] CALABRESE
L H,DODICK D W,SCHWEDT
T J,et al. Narrative review:reversible
cerebral vasoconstriction syndromes[J]. Ann Intern Med,2007,146(1):34-44.
[58] PERILLO T,PAOLELLA C,PERROTTA G,et al. Reversible cerebral
vasoconstriction syndrome:review of neuroimaging
findings[J]. Radiol Med,2022,127(9):981-990.
[59] CHEN
C Y,CHEN S P,FUH J L,et al. Vascular wall imaging in reversible cerebral vasoconstriction
syndrome—a 3-T contrast-enhanced MRI study[J/OL]. J
Headache Pain,2018,19(1):74[2023-11-10].
https://doi.org/10.1186/s10194-018-0906-7. |